According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are โฌ62.3 M. In 2023 the company made an earning of -โฌ0.29 B an increase over its 2022 earnings that were of -โฌ0.88 B.The earnings displayed on this page is the company's Pretax Income.